Literature DB >> 20926734

Ulcerative typhlocolitis associated with Helicobacter mastomyrinus in telomerase-deficient mice.

K A Eaton1, J S Opp, B M Gray, I L Bergin, V B Young.   

Abstract

Telomerase deficiency induces early senescence and defects in proliferating cell populations, but in mice it has not been associated with inflammatory bowel disease. Genetically engineered mice lacking either telomerase reverse transcriptase (TERT) or telomerase RNA were examined for chronic diarrhea and wasting. Affected mice had pasty stools, thickened nondistensible colon walls, and contracted ceca. Histologically, the cecal mucosa was largely replaced by inflammatory infiltrate consisting of plasma cells, neutrophils, lymphocytes, and macrophages with marked widespread fibrosis and ulceration. Remaining epithelium was disorganized and hyperplastic, with multifocal dysplasia. Colonic mucosa was markedly hyperplastic with similar inflammation and epithelial dysplasia. Multifocal adenomatous hyperplasia, but no inflammation, was present in the small intestine. Microaerophilic spiral bacteria with 16S rRNA gene sequences identical to Helicobacter mastomyrinus were isolated from the colon and cecum. Severe granulomatous typhlocolitis without epithelial dysplasia developed in germ-free recombination-activating gene (RAG) knockout (KO) recipients of CD4+ T cells and inoculated with cecal contents from affected TERT KO mice and in specific pathogen-free recipient RAG KO mice and interleukin-10 KO mice inoculated with H mastomyrinus. Typhlocolitis in mice given H mastomyrinus was more severe than in mice given Helicobacter hepaticus. Telomerase-deficient mice are susceptible to helicobacter-associated typhlocolitis. H mastomyrinus causes severe disease in susceptible mouse strains.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926734      PMCID: PMC4284821          DOI: 10.1177/0300985810383876

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  57 in total

1.  Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.

Authors:  R Duchmann; E Schmitt; P Knolle; K H Meyer zum Büschenfelde; M Neurath
Journal:  Eur J Immunol       Date:  1996-04       Impact factor: 5.532

2.  Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota.

Authors:  Carole J Kuehl; Heather D Wood; Terence L Marsh; Thomas M Schmidt; Vincent B Young
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Natural colonization with Helicobacter species and the development of inflammatory bowel disease in interleukin-10-deficient mice.

Authors:  Li Zhang; Stephen J Danon; Martin Grehan; Vivian Chan; Adrian Lee; Hazel Mitchell
Journal:  Helicobacter       Date:  2005-06       Impact factor: 5.753

4.  The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice.

Authors:  K A Eaton; M Mefford; T Thevenot
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

Review 5.  Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease.

Authors:  S Wirtz; M F Neurath
Journal:  Int J Colorectal Dis       Date:  2000-06       Impact factor: 2.571

Review 6.  Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

7.  Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice.

Authors:  Maciej Chichlowski; Julie M Sharp; Deborah A Vanderford; Matthew H Myles; Laura P Hale
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

8.  Cryptosporidium parvum initiates inflammatory bowel disease in germfree T cell receptor-alpha-deficient mice.

Authors:  R E Sacco; J S Haynes; J A Harp; W R Waters; M J Wannemuehler
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

9.  Telomerase reverse transcriptase delays aging in cancer-resistant mice.

Authors:  Antonia Tomás-Loba; Ignacio Flores; Pablo J Fernández-Marcos; María L Cayuela; Antonio Maraver; Agueda Tejera; Consuelo Borrás; Ander Matheu; Peter Klatt; Juana M Flores; José Viña; Manuel Serrano; Maria A Blasco
Journal:  Cell       Date:  2008-11-14       Impact factor: 41.582

10.  Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation.

Authors:  Dionysios A Antonopoulos; Susan M Huse; Hilary G Morrison; Thomas M Schmidt; Mitchell L Sogin; Vincent B Young
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

View more
  13 in total

1.  Helicobacter saguini, a Novel Helicobacter Isolated from Cotton-Top Tamarins with Ulcerative Colitis, Has Proinflammatory Properties and Induces Typhlocolitis and Dysplasia in Gnotobiotic IL-10-/- Mice.

Authors:  Z Shen; A Mannion; M T Whary; S Muthupalani; A Sheh; Y Feng; G Gong; P Vandamme; H R Holcombe; B J Paster; J G Fox
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

2.  Telomerase directly regulates NF-κB-dependent transcription.

Authors:  Arkasubhra Ghosh; Gaye Saginc; Shi Chi Leow; Ekta Khattar; Eun Myong Shin; Ting Dong Yan; Marc Wong; Zhizhuo Zhang; Guoliang Li; Wing-Kin Sung; Jianbiao Zhou; Wee Joo Chng; Shang Li; Edison Liu; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2012-11-18       Impact factor: 28.824

Review 3.  Nonproliferative and Proliferative Lesions of the Gastrointestinal Tract, Pancreas and Salivary Glands of the Rat and Mouse.

Authors:  Thomas Nolte; Patricia Brander-Weber; Charles Dangler; Ulrich Deschl; Michael R Elwell; Peter Greaves; Richard Hailey; Michael W Leach; Arun R Pandiri; Arlin Rogers; Cynthia C Shackelford; Andrew Spencer; Takuji Tanaka; Jerrold M Ward
Journal:  J Toxicol Pathol       Date:  2016-02-13       Impact factor: 1.628

4.  Prevalence of murine Helicobacter spp. Infection is reduced by restocking research colonies with Helicobacter-free mice.

Authors:  Jennifer Ls Lofgren; Michael Esmail; Melissa Mobley; Amanda McCabe; Nancy S Taylor; Zeli Shen; Susan Erdman; Christine Hewes; Mark T Whary; James G Fox
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-07       Impact factor: 1.232

5.  Hematopoietic lineage skewing and intestinal epithelia degeneration in aged mice with telomerase RNA component deletion.

Authors:  Jichun Chen; Mark A Bryant; James J Dent; Yu Sun; Marie J Desierto; Neal S Young
Journal:  Exp Gerontol       Date:  2015-10-30       Impact factor: 4.032

6.  Effects of medicated diet to eradicate Helicobacter spp. on growth, pathology, and infection status in Rag1-/- and nude mice.

Authors:  Caroline M Garrett; Dillon Muth; Julie Watson
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-05       Impact factor: 1.232

7.  Replication Study: Intestinal inflammation targets cancer-inducing activity of the microbiota.

Authors:  Kathryn Eaton; Ali Pirani; Evan S Snitkin
Journal:  Elife       Date:  2018-10-08       Impact factor: 8.140

8.  Giardia Infection of the Small Intestine Induces Chronic Colitis in Genetically Susceptible Hosts.

Authors:  Sara M Dann; Christine H Y Le; Elaine M Hanson; Matthew C Ross; Lars Eckmann
Journal:  J Immunol       Date:  2018-06-13       Impact factor: 5.422

9.  Comparing Mouse Health Monitoring Between Soiled-bedding Sentinel and Exhaust Air Dust Surveillance Programs.

Authors:  Darya Mailhiot; Allison M Ostdiek; Kerith R Luchins; Chago J Bowers; Betty R Theriault; George P Langan
Journal:  J Am Assoc Lab Anim Sci       Date:  2019-12-20       Impact factor: 1.232

10.  Dose-dependent incidence of hepatic tumors in adult mice following perinatal exposure to bisphenol A.

Authors:  Caren Weinhouse; Olivia S Anderson; Ingrid L Bergin; David J Vandenbergh; Joseph P Gyekis; Marc A Dingman; Jingyun Yang; Dana C Dolinoy
Journal:  Environ Health Perspect       Date:  2014-02-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.